While this panel has grown in recent years, many experts believe additional biomarkers should also be incorporated as ...
Discover why Rigel Pharma (RIGL) is a contrarian biotech BUY with surging revenues, strong drug sales, and 20-30% upside ...
"Race Oncology secures HREC approval for Phase Ia/Ib RC220 trial" was originally created and published by Clinical Trials ...
Special Report: Race Oncology has taken a significant step forward in the clinical development of its next-generation cancer ...
Temple & Webster Group Ltd (ASX: TPW) and West African Resources Ltd (ASX: WAF) are two of four ASX shares falling on ...
Unusually, Firebrick Pharma has shared the results of an investor survey that doesn't entirely cast the company in a ...
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Nov. 27, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ('HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that new and updated data from ...
A 75-year-old man with non-small cell lung cancer shows radiologic enlargement after neoadjuvant therapy; however, ...